{"entity":{"type":"insider","cik":"0001575408","url":"/insider/0001575408","json_url":"/insider/0001575408.json","name":"Islam Saqib","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":22,"first":"2014-11-04","last":"2025-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Islam Saqib","source":"filing","n_filings":22,"first_seen":"2014-11-04","last_seen":"2025-03-05"}],"transactions":[{"id":4248827,"accession":"0001104659-25-021005","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-25-021005","line_url":"/filing/0001104659-25-021005","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":54.23787387755102,"price_display":"54.24","price_state":"stated","total_value":2657655.82,"total_display":"2,657,655.82","total_whole":"2,657,656","shares_owned_after":968469.0,"shares_owned_after_display":"968,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider","n_lines":5},{"id":4547775,"accession":"0001104659-25-016617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-016617","line_url":"/filing/0001104659-25-016617","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29328.0,"shares_display":"29,328","price_per_share":60.297353668848885,"price_display":"60.30","price_state":"stated","total_value":1768400.7884,"total_display":"1,768,400.79","total_whole":"1,768,401","shares_owned_after":1039693.0,"shares_owned_after_display":"1,039,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-24","scope":"insider","n_lines":2},{"id":4111430,"accession":"0001104659-25-015218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-015218","line_url":"/filing/0001104659-25-015218#line-1","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10672.0,"shares_display":"10,672","price_per_share":59.9222,"price_display":"59.92","price_state":"stated","total_value":639489.7184,"total_display":"639,489.72","total_whole":"639,490","shares_owned_after":1063953.0,"shares_owned_after_display":"1,063,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-19","scope":"insider"},{"id":5043065,"accession":"0001104659-25-012363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-012363","line_url":"/filing/0001104659-25-012363#line-1","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48000.0,"shares_display":"48,000","price_per_share":53.2966,"price_display":"53.30","price_state":"stated","total_value":2558236.8,"total_display":"2,558,236.80","total_whole":"2,558,237","shares_owned_after":1002502.0,"shares_owned_after_display":"1,002,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":2964303,"accession":"0001104659-24-125534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-125534","line_url":"/filing/0001104659-24-125534","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":41.374639175510204,"price_display":"41.37","price_state":"stated","total_value":2027357.3196,"total_display":"2,027,357.32","total_whole":"2,027,357","shares_owned_after":1018357.0,"shares_owned_after_display":"1,018,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider","n_lines":2},{"id":3153916,"accession":"0001104659-24-096872","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-096872","line_url":"/filing/0001104659-24-096872","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":40.57210330612245,"price_display":"40.57","price_state":"stated","total_value":1988033.062,"total_display":"1,988,033.06","total_whole":"1,988,033","shares_owned_after":1079968.0,"shares_owned_after_display":"1,079,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-04","scope":"insider","n_lines":3},{"id":2471805,"accession":"0001104659-24-068675","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-068675","line_url":"/filing/0001104659-24-068675","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":39.90026506122449,"price_display":"39.90","price_state":"stated","total_value":1955112.988,"total_display":"1,955,112.99","total_whole":"1,955,113","shares_owned_after":1128128.0,"shares_owned_after_display":"1,128,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider","n_lines":4},{"id":5206832,"accession":"0001104659-21-128168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-128168","line_url":"/filing/0001104659-21-128168#line-1","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10083.0,"shares_display":"10,083","price_per_share":58.6658,"price_display":"58.67","price_state":"stated","total_value":591527.2614,"total_display":"591,527.26","total_whole":"591,527","shares_owned_after":779218.0,"shares_owned_after_display":"779,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-20","filed_date":"2021-10-20","scope":"insider"},{"id":5206828,"accession":"0001104659-21-127704","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-127704","line_url":"/filing/0001104659-21-127704#line-2","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14077.0,"shares_display":"14,077","price_per_share":58.8103,"price_display":"58.81","price_state":"stated","total_value":827872.5931,"total_display":"827,872.59","total_whole":"827,873","shares_owned_after":769135.0,"shares_owned_after_display":"769,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-19","scope":"insider"},{"id":5206823,"accession":"0001104659-21-127704","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-127704","line_url":"/filing/0001104659-21-127704#line-1","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38340.0,"shares_display":"38,340","price_per_share":58.5943,"price_display":"58.59","price_state":"stated","total_value":2246505.462,"total_display":"2,246,505.46","total_whole":"2,246,505","shares_owned_after":783212.0,"shares_owned_after_display":"783,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-19","scope":"insider"},{"id":5502028,"accession":"0001104659-21-094094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-094094","line_url":"/filing/0001104659-21-094094#line-2","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18572.0,"shares_display":"18,572","price_per_share":77.6842,"price_display":"77.68","price_state":"stated","total_value":1442750.9624,"total_display":"1,442,750.96","total_whole":"1,442,751","shares_owned_after":821552.0,"shares_owned_after_display":"821,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-20","scope":"insider"},{"id":5502025,"accession":"0001104659-21-094094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-094094","line_url":"/filing/0001104659-21-094094#line-1","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43928.0,"shares_display":"43,928","price_per_share":76.089,"price_display":"76.09","price_state":"stated","total_value":3342437.592,"total_display":"3,342,437.59","total_whole":"3,342,438","shares_owned_after":840124.0,"shares_owned_after_display":"840,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-20","scope":"insider"},{"id":4948157,"accession":"0001104659-21-052683","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-052683","line_url":"/filing/0001104659-21-052683#line-2","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24075.0,"shares_display":"24,075","price_per_share":66.3875,"price_display":"66.39","price_state":"stated","total_value":1598279.0625,"total_display":"1,598,279.06","total_whole":"1,598,279","shares_owned_after":884052.0,"shares_owned_after_display":"884,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-20","filed_date":"2021-04-20","scope":"insider"},{"id":4948152,"accession":"0001104659-21-052683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-052683","line_url":"/filing/0001104659-21-052683#line-1","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38425.0,"shares_display":"38,425","price_per_share":69.0391,"price_display":"69.04","price_state":"stated","total_value":2652827.4175,"total_display":"2,652,827.42","total_whole":"2,652,827","shares_owned_after":908127.0,"shares_owned_after_display":"908,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-20","scope":"insider"},{"id":4281347,"accession":"0001104659-21-006327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-006327","line_url":"/filing/0001104659-21-006327#line-2","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2199.0,"shares_display":"2,199","price_per_share":78.7541,"price_display":"78.75","price_state":"stated","total_value":173180.2659,"total_display":"173,180.27","total_whole":"173,180","shares_owned_after":1222997.0,"shares_owned_after_display":"1,222,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-21","scope":"insider"},{"id":4281344,"accession":"0001104659-21-006327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-006327","line_url":"/filing/0001104659-21-006327#line-1","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60301.0,"shares_display":"60,301","price_per_share":78.5428,"price_display":"78.54","price_state":"stated","total_value":4736209.3828,"total_display":"4,736,209.38","total_whole":"4,736,209","shares_owned_after":1225196.0,"shares_owned_after_display":"1,225,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider"},{"id":3038963,"accession":"0001209191-20-015626","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-015626","line_url":"/filing/0001209191-20-015626#line-1","is_derivative":false,"issuer_cik":"0001575408","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001575408","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-03","scope":"insider"},{"id":2773054,"accession":"0000899866-16-000270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000270","line_url":"/filing/0000899866-16-000270#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":905.0,"shares_display":"905","price_per_share":138.91,"price_display":"138.91","price_state":"stated","total_value":125713.55,"total_display":"125,713.55","total_whole":"125,714","shares_owned_after":43799.0,"shares_owned_after_display":"43,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-03-01","scope":"insider"},{"id":2585873,"accession":"0000899866-16-000241","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899866-16-000241","line_url":"/filing/0000899866-16-000241","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1474.0,"shares_display":"1,474","price_per_share":138.07223880597016,"price_display":"138.07","price_state":"stated","total_value":203518.48,"total_display":"203,518.48","total_whole":"203,518","shares_owned_after":44704.0,"shares_owned_after_display":"44,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-08","scope":"insider","n_lines":2},{"id":2585865,"accession":"0000899866-16-000241","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899866-16-000241","line_url":"/filing/0000899866-16-000241","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1970.0,"shares_display":"1,970","price_per_share":143.4826700507614,"price_display":"143.48","price_state":"stated","total_value":282660.86,"total_display":"282,660.86","total_whole":"282,661","shares_owned_after":46178.0,"shares_owned_after_display":"46,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-05","filed_date":"2016-02-08","scope":"insider","n_lines":6},{"id":8653596,"accession":"0000899866-15-000204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000204","line_url":"/filing/0000899866-15-000204#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":950.0,"shares_display":"950","price_per_share":190.0,"price_display":"190.00","price_state":"stated","total_value":180500.0,"total_display":"180,500.00","total_whole":"180,500","shares_owned_after":36385.0,"shares_owned_after_display":"36,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-08","filed_date":"2015-12-08","scope":"insider"},{"id":8628029,"accession":"0000899866-15-000194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000194","line_url":"/filing/0000899866-15-000194#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":180.0,"price_display":"180.00","price_state":"stated","total_value":175500.0,"total_display":"175,500.00","total_whole":"175,500","shares_owned_after":37335.0,"shares_owned_after_display":"37,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-04","scope":"insider"},{"id":8556151,"accession":"0000899866-15-000187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000187","line_url":"/filing/0000899866-15-000187#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1558.0,"shares_display":"1,558","price_per_share":168.44,"price_display":"168.44","price_state":"stated","total_value":262429.52,"total_display":"262,429.52","total_whole":"262,430","shares_owned_after":38310.0,"shares_owned_after_display":"38,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-26","filed_date":"2015-10-29","scope":"insider"},{"id":8482439,"accession":"0000899866-15-000099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000099","line_url":"/filing/0000899866-15-000099#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6032.0,"shares_display":"6,032","price_per_share":181.57,"price_display":"181.57","price_state":"stated","total_value":1095230.24,"total_display":"1,095,230.24","total_whole":"1,095,230","shares_owned_after":39868.0,"shares_owned_after_display":"39,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-27","filed_date":"2015-04-30","scope":"insider"},{"id":8856112,"accession":"0000899866-15-000072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000072","line_url":"/filing/0000899866-15-000072#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":228.0,"shares_display":"228","price_per_share":180.34,"price_display":"180.34","price_state":"stated","total_value":41117.52,"total_display":"41,117.52","total_whole":"41,118","shares_owned_after":39432.0,"shares_owned_after_display":"39,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-03","scope":"insider"},{"id":8913217,"accession":"0000899866-15-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000050","line_url":"/filing/0000899866-15-000050#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (EVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":171.15,"price_display":"171.15","price_state":"stated","total_value":256725.0,"total_display":"256,725.00","total_whole":"256,725","shares_owned_after":34560.0,"shares_owned_after_display":"34,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-12","scope":"insider"},{"id":7042641,"accession":"0000899866-14-000237","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-14-000237","line_url":"/filing/0000899866-14-000237","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001575408","owner_name":"Islam Saqib","owner_display_name":"Islam Saqib","owner_url":"/insider/0001575408","role":"Officer (SVP, Chief Strat & Port. Off)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Strat & Port. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Strat & Port. Off.","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28125.0,"shares_display":"28,125","price_per_share":190.50066488888888,"price_display":"190.50","price_state":"stated","total_value":5357831.2,"total_display":"5,357,831.20","total_whole":"5,357,831","shares_owned_after":28235.0,"shares_owned_after_display":"28,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":44,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001773427","name":"SpringWorks Therapeutics, Inc.","url":"/issuer/0001773427","role":"Director, Officer (Chief Executive Officer)","n_filings":12,"first_seen":"2021-01-21","last_seen":"2025-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Director","n_filings":1,"first_seen":"2020-03-03","last_seen":"2020-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Officer (EVP, Chief Strat & Port. Off)","n_filings":9,"first_seen":"2014-11-04","last_seen":"2016-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001575408","retrieved_at":"2026-08-25T13:10:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}